N-(4-Ethoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide

Catalog No. :
ACPLDR659
CAS No. :
1775409-04-5
Molecular Formula :
C23H27N3O3
Molecular Weight :
393.49

IUPAC Name:N-(4-ethoxyphenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide

N-(4-Ethoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$322.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-Ethoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide
IUPAC NameN-(4-ethoxyphenyl)-5-methyl-12-oxo-5,5a,6,7,8,9,10,12-octahydroazepino[2,1-b]quinazoline-3-carboxamide
MDL No.MFCD28506469
Molecular FormulaC23H27N3O3
Molecular Weight393.49
SMILESO=C(C1=CC(N(C)C2N3CCCCC2)=C(C=C1)C3=O)NC4=CC=C(OCC)C=C4
InChI KeyMADMDABDECSQNT-UHFFFAOYSA-N
SynonymN-(4-ethoxyphenyl)-5-methyl-12-oxo-5H,5aH,6H,7H,8H,9H,10H,12H-azepino[2,1-b]quinazoline-3-carboxamide;Azepino[2,1-b]quinazoline-3-carboxamide, N-(4-ethoxyphenyl)-5,5a,6,7,8,9,10,12-octahydro-5-methyl-12-oxo-
CAS No.1775409-04-5

Synthetic Route by SureRoute

1. ACPLDR659 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSZPC617 route compound structure diagram
    ACSZPC617637-56-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPLDR659 route product structure diagram
    ACPLDR6591775409-04-5
Inquiry

2. ACPLDR659 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACSZPC617 route compound structure diagram
    ACSZPC617637-56-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPLDR659 route product structure diagram
    ACPLDR6591775409-04-5
Inquiry

Comments (0)